The effects of an educational program for non-physician health care providers regarding fertility preservation

2018 ◽  
Vol 26 (10) ◽  
pp. 3447-3452 ◽  
Author(s):  
Emi Takeuchi ◽  
Masashi Kato ◽  
Kayoko Miyata ◽  
Nao Suzuki ◽  
Chikako Shimizu ◽  
...  
F1000Research ◽  
2019 ◽  
Vol 7 ◽  
pp. 1890
Author(s):  
Achmad Kemal Harzif ◽  
Raymond Surya ◽  
Mila Maidarti ◽  
Ana Mariana ◽  
Bara Tracy Lovita ◽  
...  

Background: Early detection and advanced treatment increases the five-year survival rate of patients with cancer. However, long-term cancer therapy, such as chemotherapy and radiotherapy, can have negative effects, such as infertility. This study aimed to develop a standardized Indonesian questionnaire, which would be used to assess the quality of health care providers’ knowledge, attitude, and practice regarding fertility preservation in patients with cancer. Methods: A pilot study was performed in January and February 2018 at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. An existing questionnaire was translated from English to Indonesian using forward translation, back translation, expert panel, pretesting, and cognitive interviewing. Ten subspecialists in the following departments made up an expert panel, who were involved in pretesting and cognitive interviewing: pediatric hematology-oncology, hematology-oncology/internal medicine, gynecologic oncology, gynecologic immune-endocrinology, radiology-oncology, and surgical oncology. Results: The questionnaire was successfully translated. The ten respondents stated that the maximum age for women’s fertility preservation is 40 years of age (60%), 45 years of age (30%), or had no maximum age (10%). Additionally, the respondents stated that the maximum age for men’s fertility preservation is 40 years of age (30%), 50 years of age (20%), or had no maximum age (50%). The respondents’ knowledge stated that > 50% of them were aware but do not know enough about fertility preservation. The respondents stated that more than 50% of them give feedback agreeing to fertility preservation, and they always give advice about fertility preservation to their patients. Conclusion: The translation of the questionnaire followed translation steps from the World Health Organization and was adjusted based on the expert panel’s comments concerning fertility preservation. This validated questionnaire tool in Indonesian can be used for research purposes and clinical evaluation of fertility preservation among health care providers in Indonesia.


2019 ◽  
Vol 6 (3) ◽  
pp. 157-166
Author(s):  
Najla J. Alhraiwil ◽  
Razan A. AlYoussef ◽  
Nora K. AlShlash ◽  
Samar A. Amer ◽  
Nashwa M. Radwan ◽  
...  

2018 ◽  
Vol 4 (Supplement 2) ◽  
pp. 61s-61s
Author(s):  
H.J. Lin ◽  
Y. Cheng ◽  
J.L. Tang

Background: The incidence of hematologic malignancies has increased steadily in Taiwan. Along with the improvement of medical treatment, the survival of patients with hematologic malignancies has greatly improved. Cancer treatment may cause temporary or permanently infertility, which may lead to psychological distress and reduced quality of life. As patients live longer, the consequences of cancer treatments and fertility preservation are of increasing importance. Aim: The aims of this study was to understand the knowledge, needs and experiences of fertility preservation (FP) of patients with hematologic malignancies, and the perceptions and practices of healthcare providers concerning FP for patients with hematologic malignancies. This study also aimed to identify the challenges of FP in health care settings. Methods: In-depth interviews with 13 patients and 13 health care providers along with on-site observation were conducted. Results: Research findings were presented in three parts, respectively addressing patients' needs and attitudes, health care providers' perspective, and problems of current treatment procedures. In the first part, findings showed that among all the 13 interviewed patients, 10 had received counseling, and among them 4 had successfully completed FP. Most patients were unaware of infertility risk of cancer treatment and uninformed with FP information. At the time of cancer diagnosis, most patients were preoccupied with cancer treatment and own survival, but once informed, most of them expressed an aspiration to preserve fertility. In the second part, healthcare providers were found to encounter multiple barriers in initiating discussions about FP with patients, which included the health conditions of patients, the urgent need for treatment, and their perceived insufficiency in knowledge concerning FP procedures and in awareness of experiences of other cases. In the third part, the findings indicated that patients faced several challenges, including the passive attitudes of their physicians, the lack of the counselors or coordinators about FP, and the lack of collaborative guidelines or practices among different subspecialties. Conclusion: The fertility issues of patients with hematologic malignancies deserve attention, as their survival rate has been improved. To ensure the provisions of more friendly medical care resources and to improve life quality of patients with hematologic malignancies, the researcher proposed the following suggestions to the health care team: to provide patients the information concerning the infertility risks caused by cancer treatment and consultation services, establish and implement treatment procedures that incorporate FP, strengthen collaboration across subspecialties, communicate with patients about FP before the initiation of cancer treatment, and provide medical assistance to patients in needs.


2013 ◽  
Vol 31 (19) ◽  
pp. 2500-2510 ◽  
Author(s):  
Alison W. Loren ◽  
Pamela B. Mangu ◽  
Lindsay Nohr Beck ◽  
Lawrence Brennan ◽  
Anthony J. Magdalinski ◽  
...  

Purpose To update guidance for health care providers about fertility preservation for adults and children with cancer. Methods A systematic review of the literature published from March 2006 through January 2013 was completed using MEDLINE and the Cochrane Collaboration Library. An Update Panel reviewed the evidence and updated the recommendation language. Results There were 222 new publications that met inclusion criteria. A majority were observational studies, cohort studies, and case series or reports, with few randomized clinical trials. After review of the new evidence, the Update Panel concluded that no major, substantive revisions to the 2006 American Society of Clinical Oncology recommendations were warranted, but clarifications were added. Recommendations As part of education and informed consent before cancer therapy, health care providers (including medical oncologists, radiation oncologists, gynecologic oncologists, urologists, hematologists, pediatric oncologists, and surgeons) should address the possibility of infertility with patients treated during their reproductive years (or with parents or guardians of children) and be prepared to discuss fertility preservation options and/or to refer all potential patients to appropriate reproductive specialists. Although patients may be focused initially on their cancer diagnosis, the Update Panel encourages providers to advise patients regarding potential threats to fertility as early as possible in the treatment process so as to allow for the widest array of options for fertility preservation. The discussion should be documented. Sperm and embryo cryopreservation as well as oocyte cryopreservation are considered standard practice and are widely available. Other fertility preservation methods should be considered investigational and should be performed by providers with the necessary expertise.


2021 ◽  
Vol 14 (1) ◽  
pp. 81
Author(s):  
Sarrah Ayuandari ◽  
Nurida Khasanah ◽  
IsmiW Riyanti ◽  
Agung Dewanto ◽  
DiannisaIkarumi Enisar Sangun ◽  
...  

2006 ◽  
Vol 92 (1) ◽  
pp. 7-10
Author(s):  
Marianne Jansen ◽  
Leonard B. Bell ◽  
Michel A. Sucher ◽  
Kimbal E. Cooper ◽  
James D. Stoehr

ABSTRACT Aftercare monitoring programs for health care professionals with documented substance abuse problems are managed differently by various states and their respective licensing boards. Many programs have reported surreptitious alcohol use as a significant concern, yet there is no clear indication of the best methods for detecting alcohol use since the detection of ethanol is difficult due to its limited half-life in saliva, urine and serum. Ethyl glucuronide (EtG), a minor metabolite of alcohol metabolism, is only present in urine when alcohol has been consumed. EtG testing may therefore improve the detection of alcohol use by health care professionals in monitored aftercare programs. This study compared urine ethanol (Medpro B panel) and urine EtG in specimens from 126 clients enrolled in Arizona’s physician health aftercare monitoring program. Each client was tested twice per month for a two-month period in 2004. Of the 504 tests, there were no positive urine ethanol results using a standard, lab determined minimum cutoff level of 20mg/dL. There were four positive EtG results (one percent positive rate) using a minimum cutoff level of 100ng/mL. The four positive EtG results imply the presence of four false negative urine ethanol results. Therefore, the results suggest that the EtG test is more sensitive for alcohol detection and should be considered for future improvements in the testing and monitoring of health care providers enrolled in aftercare programs.


Sign in / Sign up

Export Citation Format

Share Document